Tags: HCV

Press Release2 Mar 2014

The Egyptian Initiative for Personal Rights confirms that there are scientific alternatives for the provision of a cure for millions of Egyptians infected with hepatitis C viruses (HCV)

EIPR believes that the Egyptian government should negotiate with the new drug manufacturer from a position of strength as this drug cannot be imported without receiving an Egyptian license and conducting the needed clinical trials.

Press Release29 Jul 2011

World Hepatitis Day: Access to Information on the Quality, Safety and Efficacy of the "Egyptian Interferon" is a right to every HCV Patient in Egypt

The Egyptian Initiative for Personal Rights (EIPR) issued a briefing note on the World Hepatitis Day, 28 July 2011, presenting the most important features of the debate over the quality, safety and efficacy (QSE) of long-lasting interferon, produc

Tags: HCV

The Egyptian Initiative for Personal Rights confirms that there are scientific alternatives for the provision of a cure for millions of Egyptians infected with hepatitis C viruses (HCV)

World Hepatitis Day: Access to Information on the Quality, Safety and Efficacy of the "Egyptian Interferon" is a right to every HCV Patient in Egypt

EIPR

Programs

EIPR English Mailing List

Follow Us